ISSN 2415-1297 (Online)   ISSN 2415-1300 (Print)
 
             
 
Volume : 27 Issue : 1 Year : 2019
 
A Blind Study to Evaluate The Role of Alpha-Tocopherol to Reduce Methotrexate Induced Toxicities in Cancer Management [Med J Islamic World Acad Sci]
Med J Islamic World Acad Sci. 1992; 5(3): 194-198

A Blind Study to Evaluate The Role of Alpha-Tocopherol to Reduce Methotrexate Induced Toxicities in Cancer Management

Mohammad T. Aftab, S. H. M. Zaidi, Zafar S. Saify, Asif B. Rehman, Shahid Rashid
From Department of Pharmacology and Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan.

Methotrexate is the most commonly used antimetabolite, frequently producing dramatic results in a number of malignant diseases. However, the efficacy of the drug becomes limited due to unexpected and apparently quite sudden severe toxicity, which even persists despite the administration of citrovorum factor. Since alpha-tocopherol has been found to play a significant role against the development of anticancer therapy induced toxicities, a double blind study is conducted on twenty six patients, who were on prolonged Methotrexate therapy, for residue or recurrence of their head and neck malignancies. A significant decrease in renal toxicity is noted in patients who received alpha-tocopherol. Antioxidant action of alpha tocopherol probably plays an important role in this regard.

Keywords: Alpha-tocopherol, methotrexate toxicity, cancer.


Mohammad T. Aftab, S. H. M. Zaidi, Zafar S. Saify, Asif B. Rehman, Shahid Rashid. A Blind Study to Evaluate The Role of Alpha-Tocopherol to Reduce Methotrexate Induced Toxicities in Cancer Management. Med J Islamic World Acad Sci. 1992; 5(3): 194-198

Corresponding Author: Mohammad T. Aftab, Pakistan


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 











 
Copyright 2019 medicaljournal-ias.org. All Rights Reserved.